SYRS (Syros Pharmaceuticals, Inc) Earnings per share increase in current year

SYRS (Syros Pharmaceuticals, Inc) - company brandmark

The basis of the analysis is the R&D foundation of Syros Pharmaceuticals (SYRS) in the US, which creates tools for the precise control of gene expression. The annual growth rate of earnings per share visualizes the dynamics of this process, where 0.00 is recorded as the baseline value. Diversification of oncology research reduces the risk of test failures, yet a severe management crisis and debt default place the company in survival mode.

Syros Pharmaceuticals Inc. (SYRS) Earnings per share growth in current year: for the period 07/04/2022 - 03/29/2025

Financial and market metric breakdowns for syros.com (SYRS)

- current price and projected stock value:
- business market valuation indicators:
Fundamental valuation:SYRS, Syros
Core merchandise of Syros Pharmaceuticals

For the biopharmaceutical startup Syros Pharmaceuticals (SYRS), which focuses on high-cost R&D in oncology, this indicator serves as a measure of capital management efficiency. The relative EPS YoY dynamics are calculated as the percentage deviation of current earnings per share from the previous year's figures, neutralizing short-term market noise. Growth in this parameter confirms the company's ability to optimize innovation costs while minimizing the risks of deep capital drawdowns.

Direct competitors

Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|RARE: Net earnings per share growth this year|Earnings per share trend in current year BEAM|Sarepta (SRPT) - Earnings per share growth in current year|TWST - Expected net earnings per share growth this year|Earnings per share growth in current year 10x Genomics, Inc.|NTLA: Earnings per share increase in current year|Net earnings per share growth this year STOK (Stoke Corp)|Expected net earnings per share growth this year biolifesolutions.com|Earnings growth in current year WVE (Wave Life Sciences Ltd)|Expected net earnings per share growth this year Maze Therapeutics (MAZE)|SION: Net earnings per share growth this year|Expected net earnings per share growth this year Prime Medicine Bio PRME|TSHA: Earnings growth in current year|Earnings per share growth this year QURE|Net earnings per share growth this year MGTX|Earnings per share growth this year RGNX (REGENXBIO)|Earnings growth in current year SLDB|OCGN - Earnings per share growth rate in current year|Earnings per share growth in current year Pacific Biosciences of California PACB|BNTC: Earnings per share growth this year|DSGN - Earnings per share growth in current year|RCKT: Earnings per share growth in current year|FDMT - Net earnings per one share growth for the current year|Earnings per share growth rate in current year Lexeo Therapeutics Inc. (LXEO)|Earnings per share growth in current year Korro Bio Inc.|Editas Medicine (EDIT) - Expected net earnings per share growth this year|Earnings per share growth in current year Silence Therapeutics Inc. (SLN)|PRQR: Earnings per share trend in current year|Earnings growth in current year CDXS (codexis.com)|SGMO: Earnings per share growth this year|NAUT: Net earnings per share growth this year|Earnings per share growth rate in current year metagenomi.co|Precision BioSciences, Inc. (DTIL) - Earnings per share growth in current year|Earnings per share growth rate in current year Generation Bio Corp (GBIO)|Net earnings per share growth this year BOLD|exicuretx.com (XCUR) - Expected net earnings per share growth this year|Net earnings per share growth this year IMNN (Celsion Corporation)|PHIO (Phio Pharmaceuticals Corp.) - Earnings per share increase in current year|Earnings growth in current year MBIO (Mustang Bio Corp)|Net earnings per one share growth for the current year RNAZ (TransCode Therapeutics)|BNGO - Earnings per share growth in current year|APDN: Earnings per share growth in current year|BLUE: Earnings growth in current year|Net earnings per share growth this year ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Earnings growth in current year|Singular Genomics (OMIC) - Expected net earnings per share growth this year|Earnings per share growth in current year Regulus (RGLS)|TBIO - Earnings per share growth rate in current year|Earnings per share growth in current year TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Earnings per share growth rate in current year